Search Within

Andrea Knezevic

Formats
  1. Journal Article (53)
  2. Meeting Abstract (53)
  3. Research Letter (1)
Groups
  1. Department of Medicine (94)
  2. Solid Tumor Oncology Division (76)
  3. Genitourinary Oncology Service (64)
  4. Weinberg Fellows (61)
  5. Epidemiology and Biostatistics (58)
  6. Biostatistics Service (49)

More Groups

People
  1. Darren Feldman (52)
  2. Robert Motzer (48)
  3. Martin Voss (39)
  4. Chung-Han Lee (33)
  5. Maria Carlo (31)
  6. Ritesh Kotecha (27)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (12)
  4. 2022 (14)
  5. 2021 (8)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (39)
  2. Cancer (4)
  3. Clinical Genitourinary Cancer (4)
  4. Biology of Blood and Marrow Transplantation (3)
  5. Blood (3)
  6. Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (41)
  2. Elsevier Inc. (14)
  3. American Association for Cancer Research (7)
  4. Wiley Blackwell (7)
  5. Springer (6)
  6. Elsevier Science, Inc. (5)

More Publishers

Results (107)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient portals to elicit essential patient-reported elements of communication supporting person-centered oncologic care: A pilot study of the PERSON Approach
    Journal Article

    Epstein, A. S.; Knezevic, A.; Romano, D. R.; Hoque, A.; Raj, N.; Reidy, D.; Rosa, W. E.; Cruz, E.; Calderon, C.; O'Shaughnessy, S.; more...
    JCO Clinical Cancer Informatics (2023)

    Fulltext@MSK | Save
  • A single-arm, phase II study of durvalumab (D) and tremelimumab (T) for relapsed/refractory germ cell tumors (GCT)
    Meeting Abstract

    Funt, S. A.; Knezevic, A.; Freeman, B. A.; Bolos, M.; Martorana, V.; Donoghue, M.; Khan, S.; Singh, H.; Bromberg, M.; Quinlan, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Fitzgerald, K. N.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y. B.; Zucker, M.; Lefkowitz, R. A.; Reznik, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic determinants of progression-free survival after second line of therapy (PFS-2) for patients on immunotherapy-based combination therapies for advanced clear cell renal cell carcinoma
    Meeting Abstract

    Fitzgerald, K. N.; Kotecha, R. R.; Knezevic, A.; Shapnik, N.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Adoption of an innovative "Patient Values Tab" in the electronic health record (EHR) across varied care provider roles and clinical contexts (FR206A)
    Meeting Abstract

    Desai, A. V.; Knezevic, A.; Jordan, G.; Levy, A.; Hoque, A.; Bernal, C.; Epstein, A.; Nelson, J.
    Journal of Pain and Symptom Management (2023)

    Fulltext@MSK | Save
  • Progression-free survival after second line of therapy for metastatic clear cell renal cell carcinoma in patients treated with first-line immunotherapy combinations
    Research Letter

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)lutetium-labeled anti–carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Lee, C. H.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Impact of sarcomatoid features on treatment outcomes in metastatic clear cell renal cell carcinoma treated with first-line immunotherapy combinations
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R. R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Accuracy of curability expectations in patients with gastrointestinal cancers
    Journal Article

    Agarwal, R.; Shin, P.; Knezevic, A.; Nelson, J. E.; Romano, D. R.; Bernal, C.; Desai, A. V.; Epstein, A. S.
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
    Journal Article

    Liu, Y. L.; Manning-Geist, B. L.; Knezevic, A.; Deng, L.; Bromberg, M.; Funt, S. A.; Meisel, J. L.; Zivanovic, O.; Roche, K. L.; Sonoda, Y.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save